WBR0071: Difference between revisions

Jump to navigation Jump to search
Gerald Chi (talk | contribs)
No edit summary
WikiBot (talk | contribs)
m refreshing WBR questions
 
(9 intermediate revisions by 4 users not shown)
Line 1: Line 1:
{{WBRQuestion
{{WBRQuestion
|QuestionAuthor=Gerald Chi
|QuestionAuthor=Gerald Chi (Reviewed by Yazan Daaboul)
|ExamType=USMLE Step 1
|ExamType=USMLE Step 1
|MainCategory=Genetics, Pathology
|MainCategory=Genetics
|SubCategory=Endocrine, Gastrointestinal, Genitourinary, Pulmonology, Reproductive
|SubCategory=Pulmonology
|MainCategory=Genetics, Pathology
|MainCategory=Genetics
|SubCategory=Endocrine, Gastrointestinal, Genitourinary, Pulmonology, Reproductive
|SubCategory=Pulmonology
|MainCategory=Genetics, Pathology
|MainCategory=Genetics
|SubCategory=Endocrine, Gastrointestinal, Genitourinary, Pulmonology, Reproductive
|SubCategory=Pulmonology
|MainCategory=Genetics, Pathology
|MainCategory=Genetics
|MainCategory=Genetics, Pathology
|MainCategory=Genetics
|SubCategory=Endocrine, Gastrointestinal, Genitourinary, Pulmonology, Reproductive
|MainCategory=Genetics
|MainCategory=Genetics, Pathology
|SubCategory=Pulmonology
|SubCategory=Endocrine, Gastrointestinal, Genitourinary, Pulmonology, Reproductive
|MainCategory=Genetics
|MainCategory=Genetics, Pathology
|SubCategory=Pulmonology
|SubCategory=Endocrine, Gastrointestinal, Genitourinary, Pulmonology, Reproductive
|MainCategory=Genetics
|MainCategory=Genetics, Pathology
|SubCategory=Pulmonology
|SubCategory=Endocrine, Gastrointestinal, Genitourinary, Pulmonology, Reproductive
|MainCategory=Genetics
|MainCategory=Genetics, Pathology
|SubCategory=Pulmonology
|MainCategory=Genetics, Pathology
|MainCategory=Genetics
|SubCategory=Endocrine, Gastrointestinal, Genitourinary, Pulmonology, Reproductive
|MainCategory=Genetics
|Prompt=A 5-year-old male child is evaluated for his recurrent upper respiratory tract infections. His past history is notable for vomiting due to failure to pass his first stool as a newborn. Genetic analysis reveals a homozygous deletion of three nucleotides coding for phenylalanine at amino acid position 508. At his present age, which of the following conditions is most likely to be associated with the gene defect?
|SubCategory=Pulmonology
|Explanation=Cystic fibrosis (CF) is an autosomal recessive genetic disorder that affects the lungs, pancreas, liver, and intestine. It is characterized by abnormal transport of chloride and sodium across an epithelium, leading to thick, viscous secretions.

|Prompt=A 5-year-old boy is evaluated for his recurrent upper respiratory tract infections. His past history is notable for abdominal pain and vomiting due to failure to pass his first stool as a newborn. Genetic analysis reveals a homozygous deletion of three nucleotides coding for phenylalanine at amino acid position 508. At his present age, which of the following conditions is most likely to be associated with the gene defect?
CF is caused by mutation of the gene CFTR (cystic fibrosis transmembrane conductance regulator) which encodes a member of the ATP-binding cassette (ABC) transporter superfamily. ABC proteins transport various molecules across extra- and intra-cellular membranes. The encoded protein functions as a chloride channel and controls the regulation of other transport pathways.
|Explanation=Cystic fibrosis is caused by a mutation that encodes the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The protein is primarily expressed in epithelial and blood cells. It is part of the ATP-binding cassette (ABC), or traffic APTase, gene family. Thus, it characteristically contains 2 ATP hydrolysis domains and 12 membrane-spanning alpha helixes. Its main function is a chloride channel; however it also functions to inhibit sodium transporter through the epithelial sodium channel. The "low-volume" hypothesis states that CFTR impairment in the airways leads to loss of inhibition of epithelial sodium channels, causing excessive sodium and water reabsorption and dehydration in the airways. In contrast, a "high-salt" hypothesis suggests that excess sodium and chloride are retained in the airway surface liquid due to CFTR absence.


ΔF508 is the most common type of mutation within the CFTR gene. The mutation is a deletion of the three nucleotides that comprise the codon for phenylalanine (F) at position 508. A person with the CFTRΔF508 mutation will produce an abnormal CFTR protein that lacks this phenylalanine residue. This protein does not escape the endoplasmic reticulum for further processing and fails to be translocated to the epithelial surface, rendering epithelial membranes relatively impermeable to chloride ions.
Normally in sweat glands, sodium is reabsorbed from the ductular lumen via apical sodium channels and CFTR. This process is followed by a chloride counter-ion. In patients with CF, there is impaired reabsorption of chloride leading to restricted sodium reabsorption. Accordingly, sweat in patients with CF contains high levels of sodium. This is opposite to the "low-volume" model, but consistent with the "high-salt" model.
 
In sweat ducts, there is decreased absorption of chloride through CFTR with decreased absorption of sodium through epithelial sodium channel (ENaC) which results in production of hypertonic sweats.  
 
In the gastrointestinal tract, there is decreased secretion of chloride through CFTR with increased absorption of sodium through ENaC which leads to production of dehydrated mucus.
 
In the airways, the absence of functional CFTR causes upregulation of the ENaC channel which further decreases salt and water secretion by reabsorbing sodium ions. As such, the respiratory complications in cystic fibrosis are not solely caused by the lack of chloride secretion, but instead by enhanced reabsorption of sodium and water.


Diagnosis of CF is suspected when newborns fail to pass meconium in the first 24-48 hours and thus suffer from meconium ileus. Nonetheless, some patients may remain undiagnosed until adulthood. Diagnosis is made when chloride sweat levels are elevated > 60 mmol/L (requiring pilocarpine iontophoresis and quantitative determination of chloride levels) for most patients and 2 disease-causing CFTR mutations are identified. Some patients, such as infants, may require less chloride concentrations to make the diagnosis. Although manifestations greatly vary, classically the liver, the pancreas (both exocrine and endocrine), the liver, and the genitals are involved. Although more than 1000 CFTR mutations have already been described, phenylalanine absence at position 508 accounts for the majority of mutations in Northern Europe and North America.
|AnswerA=Reduced chloride secretion by the sweat duct
|AnswerA=Reduced chloride secretion by the sweat duct
 
|AnswerAExp=Reduced chloride absorption in sweat ducts is seen in patients with CF.
|AnswerAExp=A. Reduced chloride secretion by the sweat duct is incorrect
|AnswerB=Reduced sodium reabsorption by the sweat ducts
 
|AnswerBExp=In patients with CF, there is impaired reabsorption of chloride leading to restricted sodium reabsorption. Accordingly, sweat in patients with CF contains high levels of sodium.
Reduced chloride absorption in sweat ducts is seen in patients with CF. In the absence of chloride flow in cystic fibrosis, sodium ions do not flow through ENaC despite upregulation of the ENaC channel, leading to greater salt and water loss. As such, patients' skin tastes salty, and this is commonly used to help diagnose the disease.
|AnswerB=Reduced chloride secretion by the intestinal epithelium
|AnswerBExp=B. Reduced chloride secretion by the intestinal epithelium is correct
 
Reduced chloride secretion with augmented sodium absorption resulting in water retention in the intestinal epithelium is seen in patients with CF.
|AnswerC=Decreased insulin release from the islets of Langerhans
|AnswerC=Decreased insulin release from the islets of Langerhans
|AnswerCExp=C. Decreased insulin release from the islets of Langerhans is incorrect
|AnswerCExp=The thickened secretions from the pancreas block the exocrine movement of the digestive enzymes into the duodenum and result in irreversible damage to the pancreas. This causes atrophy of the exocrine glands and progressive fibrosis. However, the endocrine pancreas might also be damaged at the advanced stage of the disease. The median age at diagnosis of cystic fibrosis-related diabetes (CFRD) is 21 years.
 
The thickened secretions from the pancreas block the exocrine movement of the digestive enzymes into the duodenum and result in irreversible damage to the pancreas. This causes atrophy of the exocrine glands and progressive fibrosis. However, the endocrine pancreas might also be damaged at the advanced stage of the disease. The median age at diagnosis of cystic fibrosis-related diabetes (CFRD) is 21 years.
|AnswerD=Loss of migration of neurons to submucosa and muscularis propria of the colon
|AnswerD=Loss of migration of neurons to submucosa and muscularis propria of the colon
|AnswerDExp=D. Loss of migration of neurons to submucosa and muscularis propria of the colon is incorrect
|AnswerDExp=Hirschsprung's disease is characterized by the loss of migration of neurons to submucosa and muscularis propria of the colon.
 
|AnswerE=Acquired absence of the vas deferens
During normal fetal development, cells from the neural crest migrate into the colon to form Auerbach's plexus and Meissner's plexus. In Hirschprung's disease, the migration is not complete and part of the colon lacks these nerve bodies that regulate the activity of the colon. The affected segment of the colon cannot relax and may lead to meconium ileus.
|AnswerEExp=The majority of male patients with CF are diagnosed with congenital bilateral absence of the vas deferens. It is a frequent finding in these patients and in most if not all children born with cystic fibrosis as well. In some males, this may be the only feature suggesting an underlying CFTR mutation.
|AnswerE=Congenital absence of the vas deferens
|EducationalObjectives=Normally in sweat glands, sodium is reabsorbed from the ductular lumen via apical sodium channels and CFTR. This process is followed by a chloride counter-ion. In patients with CF, there is impaired reabsorption of chloride leading to restricted sodium reabsorption. Accordingly, sweat in patients with CF contains high levels of sodium.
|AnswerEExp=E. Congenital absence of the vas deferens is incorrect
|References=Antunovic SS, Lukac M, Vujovic D. Longitudinal cystic fibrosis care. ''Clin Pharmacol Ther''. 2013;93(1):86-97
Obstructive azoospermia and infertility are found in 95% of the affected CF males who survive to adulthood; bilateral absence of the vas deferens is a frequent finding in these patients. In some males, this may be the only feature suggesting an underlying CFTR mutation.
<br>
Rigot JM, Lafitte JJ, Dumur V, et al. Cystic fibrosis and congenital absence of the vas deferens. ''N Engl J Med''. 1991;325(1):64-5.
<br>
O'Sullivan BP, Freedman SD. Cystic fibrosis. ''Lancet''.373(9678):1891-1904.
<br>
Rowe SM, Miller S, Sorscher EJ. Cystic fibrosis. ''N Engl J Med''. 2005;352:1992-2001.
|RightAnswer=B
|RightAnswer=B
|WBRKeyword=cystic, fibrosis, cystic fibrosis, sweat, duct, chloride, sodium, secretion, absorption, CFTR, gene, CFTR gene, congenital, vas, deferens,
|Approved=No
|Approved=No
}}
}}

Latest revision as of 23:14, 27 October 2020

 
Author PageAuthor::Gerald Chi (Reviewed by Yazan Daaboul)
Exam Type ExamType::USMLE Step 1
Main Category MainCategory::Genetics
Sub Category SubCategory::Pulmonology
Prompt [[Prompt::A 5-year-old boy is evaluated for his recurrent upper respiratory tract infections. His past history is notable for abdominal pain and vomiting due to failure to pass his first stool as a newborn. Genetic analysis reveals a homozygous deletion of three nucleotides coding for phenylalanine at amino acid position 508. At his present age, which of the following conditions is most likely to be associated with the gene defect?]]
Answer A AnswerA::Reduced chloride secretion by the sweat duct
Answer A Explanation AnswerAExp::Reduced chloride absorption in sweat ducts is seen in patients with CF.
Answer B AnswerB::Reduced sodium reabsorption by the sweat ducts
Answer B Explanation AnswerBExp::In patients with CF, there is impaired reabsorption of chloride leading to restricted sodium reabsorption. Accordingly, sweat in patients with CF contains high levels of sodium.
Answer C AnswerC::Decreased insulin release from the islets of Langerhans
Answer C Explanation [[AnswerCExp::The thickened secretions from the pancreas block the exocrine movement of the digestive enzymes into the duodenum and result in irreversible damage to the pancreas. This causes atrophy of the exocrine glands and progressive fibrosis. However, the endocrine pancreas might also be damaged at the advanced stage of the disease. The median age at diagnosis of cystic fibrosis-related diabetes (CFRD) is 21 years.]]
Answer D AnswerD::Loss of migration of neurons to submucosa and muscularis propria of the colon
Answer D Explanation AnswerDExp::Hirschsprung's disease is characterized by the loss of migration of neurons to submucosa and muscularis propria of the colon.
Answer E AnswerE::Acquired absence of the vas deferens
Answer E Explanation [[AnswerEExp::The majority of male patients with CF are diagnosed with congenital bilateral absence of the vas deferens. It is a frequent finding in these patients and in most if not all children born with cystic fibrosis as well. In some males, this may be the only feature suggesting an underlying CFTR mutation.]]
Right Answer RightAnswer::B
Explanation [[Explanation::Cystic fibrosis is caused by a mutation that encodes the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The protein is primarily expressed in epithelial and blood cells. It is part of the ATP-binding cassette (ABC), or traffic APTase, gene family. Thus, it characteristically contains 2 ATP hydrolysis domains and 12 membrane-spanning alpha helixes. Its main function is a chloride channel; however it also functions to inhibit sodium transporter through the epithelial sodium channel. The "low-volume" hypothesis states that CFTR impairment in the airways leads to loss of inhibition of epithelial sodium channels, causing excessive sodium and water reabsorption and dehydration in the airways. In contrast, a "high-salt" hypothesis suggests that excess sodium and chloride are retained in the airway surface liquid due to CFTR absence.

Normally in sweat glands, sodium is reabsorbed from the ductular lumen via apical sodium channels and CFTR. This process is followed by a chloride counter-ion. In patients with CF, there is impaired reabsorption of chloride leading to restricted sodium reabsorption. Accordingly, sweat in patients with CF contains high levels of sodium. This is opposite to the "low-volume" model, but consistent with the "high-salt" model.

Diagnosis of CF is suspected when newborns fail to pass meconium in the first 24-48 hours and thus suffer from meconium ileus. Nonetheless, some patients may remain undiagnosed until adulthood. Diagnosis is made when chloride sweat levels are elevated > 60 mmol/L (requiring pilocarpine iontophoresis and quantitative determination of chloride levels) for most patients and 2 disease-causing CFTR mutations are identified. Some patients, such as infants, may require less chloride concentrations to make the diagnosis. Although manifestations greatly vary, classically the liver, the pancreas (both exocrine and endocrine), the liver, and the genitals are involved. Although more than 1000 CFTR mutations have already been described, phenylalanine absence at position 508 accounts for the majority of mutations in Northern Europe and North America.
Educational Objective: Normally in sweat glands, sodium is reabsorbed from the ductular lumen via apical sodium channels and CFTR. This process is followed by a chloride counter-ion. In patients with CF, there is impaired reabsorption of chloride leading to restricted sodium reabsorption. Accordingly, sweat in patients with CF contains high levels of sodium.
References: Antunovic SS, Lukac M, Vujovic D. Longitudinal cystic fibrosis care. Clin Pharmacol Ther. 2013;93(1):86-97
Rigot JM, Lafitte JJ, Dumur V, et al. Cystic fibrosis and congenital absence of the vas deferens. N Engl J Med. 1991;325(1):64-5.
O'Sullivan BP, Freedman SD. Cystic fibrosis. Lancet.373(9678):1891-1904.
Rowe SM, Miller S, Sorscher EJ. Cystic fibrosis. N Engl J Med. 2005;352:1992-2001.]]

Approved Approved::No
Keyword WBRKeyword::cystic, WBRKeyword::fibrosis, WBRKeyword::cystic fibrosis, WBRKeyword::sweat, WBRKeyword::duct, WBRKeyword::chloride, WBRKeyword::sodium, WBRKeyword::secretion, WBRKeyword::absorption, WBRKeyword::CFTR, WBRKeyword::gene, WBRKeyword::CFTR gene, WBRKeyword::congenital, WBRKeyword::vas, WBRKeyword::deferens
Linked Question Linked::
Order in Linked Questions LinkedOrder::